Dr. Jortani is the Director of Research and Development at PGXL. He is also a member of the faculty at the University of Louisville School of Medicine where he directs the Forensic Toxicology Program (FTP), serves as the director of the toxicology section of the University of Louisville Hospital's clinical laboratory, and is the associate director of the Diagnostic Reference Laboratory. Dr. Jortani has directed numerous clinical trials involving in vitro diagnostics in the areas of clinical chemistry, therapeutic drug monitoring and pharmacogenetics. His specialties and research interests include Clinical Toxicology, discovery and development of biomarkers, proteomics and pharmacogenetics. His research interests also include detection and measurement of drugs, therapeutics and poisons, herbal medicine poisonings, and the use of pharmacogenetics in postmortem investigations. He belongs to several national organizations in the area of laboratory medicine such as the College of American Pathologists and the American Association for Clinical Chemistry. He also serves on the editorial boards for Clinica Chemica Acta and Clinical Proteomics.

What brings him to PGXL? Dr. Jortani's expertise in therapeutic drug monitoring and toxicology, his experience in designing and conducting clinical trials and studies, and his expertise as a board certified clinical chemist.